PA
NUTX

Pinnacle Associates’s Nutex Health NUTX Stock Holding History

Pinnacle Associates’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,000
Closed -$249K – 872
2025
Q2 		$249K Buy
+2,000
New +$258K ﹤0.01% 780

Other funds holding NUTX

TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Pinnacle Associates's NUTX Position: Q3 2025 in Review

Pinnacle Associates sold out of Nutex Health (NUTX) in Q3 2025, closing a stake of 2,000 shares — an estimated $249K sold.

Pinnacle Associates first reported a position in NUTX in Q2 2025 and held it in 1 quarter. The position peaked at $249K in Q2 2025. 95 funds tracked by Wall St. Rank hold NUTX as of Q3 2025.

  • Pinnacle Associates reported no remaining Nutex Health position as of Q3 2025 after selling out during the quarter.
  • Pinnacle Associates sold 2,000 Nutex Health shares in Q3 2025, an estimated $249K.
  • Pinnacle Associates first reported a position in Nutex Health in Q2 2025 and held it in 1 quarter.
  • Pinnacle Associates's Nutex Health position peaked at $249K in Q2 2025.
  • 95 funds tracked by Wall St. Rank held Nutex Health as of Q3 2025.

Based on Pinnacle Associates's 13F filing for Q3 2025, filed 13 Nov 2025.